SARS-CoV-2 Spike Protein Destabilizes Microvascular Homeostasis.
Level 5 - mechanism / opinion, no new human data
In vitro bench research, computational modeling, and ex vivo tissue analyses
PubMed 34935423 · doi:10.1128/Spectrum.00735-21
What was done
The authors evaluated human lung tissues from uninfected and SARS-CoV-2-infected individuals using immunofluorescence microscopy to examine ACE2 expression. They exposed primary human pulmonary alveolar epithelial cells and primary human aortic endothelial cells ex vivo to SARS-CoV-2 spike protein and bradykinin. In silico modeling was used to identify potential bradykinin receptor B2 antagonists, and the inhibitory effect of aspirin against bradykinin-induced endothelial dysfunction was evaluated in vitro.
What was found
The abstract reports no specific quantitative values, percentages, or effect sizes. Qualitatively, ACE2 was highly expressed in normal alveolar epithelial cells and reduced in SARS-CoV-2-infected lung tissue. In primary cell cultures, exposure to spike protein alone downregulated ACE2 in epithelial and endothelial cells, and triggered endothelial cell dysfunction, caspase activation, and apoptosis. Bradykinin stimulation induced calcium signaling, increased von Willebrand Factor expression, and decreased Krüppel-like Factor 2 expression without impairing viability. In vitro, aspirin suppressed bradykinin-mediated signaling and endothelial dysfunction.
Why it matters
The study provides mechanistic evidence that the SARS-CoV-2 spike protein can directly impair vascular endothelial integrity independent of whole-virus replication. It also highlights bradykinin signaling as a potential contributor to COVID-19-related microvascular pathology and suggests a mechanistic rationale for evaluating aspirin as a modulator of this pathway.
Limits
Findings are derived primarily from in vitro cell cultures, computational docking, and observational tissue microscopy. The abstract does not specify sample sizes for human lung specimens, cell culture replicates, or quantitative effect estimates. In vitro endothelial responses to isolated recombinant proteins may not fully recapitulate complex in vivo vascular physiology, systemic immune responses, or clinical COVID-19 coagulopathy.
Cited by
- supports In vitro studies have demonstrated that exposing cultured cells directly to SARS-CoV-2 spike protein activates cell signaling pathways that trigger cell death (cytotoxicity).